Benefits of resistant starch type 2 for patients with end-stage renal disease under maintenance hemodialysis: a systematic review and meta-analysis
Linpei Jia, Xingtong Dong, Xiaoxia Li, Rufu Jia, Hongliang Zhang
Abstract
Our results suggest that RS2 may improve the residual renal function of patients under MHD and mitigate a proinflammatory response.
Topics & Concepts
End stage renal diseaseMeta-analysisHemodialysisMedicineInternal medicineSystematic reviewUrologyIntensive care medicineSurgeryMEDLINEChemistryBiochemistryDialysis and Renal Disease ManagementKidney Stones and Urolithiasis TreatmentsChronic Kidney Disease and Diabetes